Paradoxical GH increase after oral glucose load in subjects with and without acromegaly.

Ceccato, F; Vedolin, C K; Voltan, G; Antonelli, G; Barbot, M; Basso, D; Regazzo, D; Scaroni, C; Occhi, G

Ceccato, F; Vedolin, C K; Voltan, G; Antonelli, G; Barbot, M; Basso, D; Regazzo, D; Scaroni, C; Occhi, G.

Afiliação

Ceccato F; Department of Medicine DIMED, University of Padova, Padua, Italy.
Vedolin CK; Endocrine Disease Unit, University-Hospital of Padova, Padua, Italy.
Voltan G; Department of Medicine DIMED, University of Padova, Padua, Italy.
Antonelli G; Endocrine Disease Unit, University-Hospital of Padova, Padua, Italy.
Barbot M; Department of Medicine DIMED, University of Padova, Padua, Italy.
Basso D; Endocrine Disease Unit, University-Hospital of Padova, Padua, Italy.
Regazzo D; Department of Medicine DIMED, University of Padova, Padua, Italy.
Scaroni C; Laboratory Medicine, University-Hospital of Padova, Padua, Italy.
Occhi G; Department of Medicine DIMED, University of Padova, Padua, Italy.

J Endocrinol Invest ; 47(1): 213-221, 2024 Jan.

Article em En | MEDLINE | ID: mdl-37344722

Assuntos

Acromegalia; Hormônio do Crescimento Humano; Humanos; Acromegalia/epidemiologia; Acromegalia/metabolismo; Glucose/metabolismo; Fator de Crescimento Insulin-Like I/metabolismo; Hormônio do Crescimento Humano/metabolismo; Estudos de Casos e Controles

Palavras-chave

Acromegaly, IGF-1; GIP; Oral glucose tolerance test; Paradoxical response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acromegalia / Hormônio do Crescimento Humano Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Endocrinol Invest Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google